Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Download PDF
June 15, 2016
/
News
Share
the Post
Related
Posts
Strategies to Secure Access to Generic HCV Medicines
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Part 1: What is hepatitis C and how is it diagnosed?
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
